Multimodal biomarkers to predict dementia-free survival and cognitive decline in mild cognitive impairment with Lewy bodies
Blood, EEG and MRI biomarkers of dementia with Lewy bodies, neurodegeneration and Alzheimer's co-pathology demonstrate utility for prognosis in MCI-LB. Combining biomarkers across modalities improves prognostic accuracy.
Authors
- Paul C. Donaghy (ORCID: https://orcid.org/0000-0001-7195-4846)
- Jahfer Hasoon (ORCID: https://orcid.org/0000-0002-0989-1175)
- Alan J. Thomas
- Julia Schumacher
- Calum A. Hamilton
- John-Paul Taylor
- Michael Firbank
- Sean J. Colloby
Institutions
- NIHR Newcastle Biomedical Research Centre (GB)
- University of Rostock (DE)
- Newcastle University (GB)
Publication Details
- Journal
- Parkinsonism & Related Disorders
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1016/j.parkreldis.2026.108265
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alzheimer's Society
- National Institute for Health and Care Research
- Department of Health and Social Care
- Newcastle University
- Newcastle upon Tyne Hospitals NHS Foundation Trust
- Medical Research Council
- NIHR Newcastle Biomedical Research Centre